168 related articles for article (PubMed ID: 2783375)
21. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
Shimoyama M; Tobinai K; Yamaguchi K; Hirashima K; Itoh S; Konishi H; Mikuni C; Togawa A; Hotta T; Toyoda N
Jpn J Clin Oncol; 1992 Dec; 22(6):406-10. PubMed ID: 1291757
[TBL] [Abstract][Full Text] [Related]
23. Pentostatin in hairy cell leukemia: treatment by the special exception mechanism.
Grem JL; King SA; Cheson BD; Leyland-Jones B; Wittes RE
J Natl Cancer Inst; 1989 Mar; 81(6):448-53. PubMed ID: 2783980
[TBL] [Abstract][Full Text] [Related]
24. Deoxycoformycin in therapy of refractory lymphoid neoplasms.
Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623
[TBL] [Abstract][Full Text] [Related]
25. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.
Tallman MS; Hakimian D; Variakojis D; Koslow D; Sisney GA; Rademaker AW; Rose E; Kaul K
Blood; 1992 Nov; 80(9):2203-9. PubMed ID: 1358262
[TBL] [Abstract][Full Text] [Related]
26. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
27. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
[TBL] [Abstract][Full Text] [Related]
28. What is the choice of treatment for hairy cell leukemia?
Golomb HM; Ratain MJ; Moormeier J
J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730
[No Abstract] [Full Text] [Related]
29. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.
Dillman RO; Mick R; McIntyre OR
J Clin Oncol; 1989 Apr; 7(4):433-8. PubMed ID: 2784491
[TBL] [Abstract][Full Text] [Related]
30. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
Seymour JF; Talpaz M; Kurzrock R
Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
[TBL] [Abstract][Full Text] [Related]
31. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia.
Bardawil RG; Groves C; Ratain MJ; Golomb HM; Vardiman JW
Am J Clin Pathol; 1986 Feb; 85(2):194-201. PubMed ID: 3946302
[TBL] [Abstract][Full Text] [Related]
32. Low-dose deoxycoformycin in the treatment of hairy cell leukemia.
Kraut EH; Bouroncle BA; Grever MR
Blood; 1986 Nov; 68(5):1119-22. PubMed ID: 3490287
[TBL] [Abstract][Full Text] [Related]
33. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
34. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
35. Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2'-deoxycoformycin.
Saven A; Piro LD
Ann Intern Med; 1993 Aug; 119(4):278-83. PubMed ID: 8101069
[TBL] [Abstract][Full Text] [Related]
36. [Hairy cell leukemia successfully treated with deoxycoformycin].
Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
[TBL] [Abstract][Full Text] [Related]
37. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
38. Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients.
Rafel M; Cervantes F; Beltrán JM; Zuazu F; Hernández Nieto L; Rayón C; García Talavera J; Montserrat E
Cancer; 2000 Jan; 88(2):352-7. PubMed ID: 10640967
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
Ng JP; Nolan B; Chan-Lam D; Coup AJ; McKenna D
Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
[TBL] [Abstract][Full Text] [Related]
40. Hairy-cell leukemia: biology and treatment.
Golde DW; Jacobs AD; Glaspy JA; Champlin RE
Semin Hematol; 1986 Jul; 23(3 Suppl 1):3-9. PubMed ID: 3526560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
